May 29, 2020
Novartis announces long-term, relapse-free survival benefit for high-risk, stage III melanoma patients treated with Tafinlar® + Mekinist® following surgery
May 27, 2020
Novartis announces new late-breaking ofatumumab data at EAN underscoring commitment to advancing treatment of relapsing forms of multiple sclerosis (RMS)
May 27, 2020
Novartis Kisqali® shows overall survival benefit in HR+/HER2- advanced breast cancer with consistent findings in patients with more aggressive disease
May 25, 2020
/R E P E A T -- New Wave Holdings Sponsors Non-Profit Coalition, Therapsil, to Launch a Medical Psilocybin Access Project for Canadians in Palliative Care/
May 24, 2020
New Wave Holdings Sponsors Non-Profit Coalition, Therapsil, to Launch a Medical Psilocybin Access Project for Canadians in Palliative Care
May 21, 2020
US Dermatophytic Onychomycosis Drug Forecast and Market Analysis 2020-2028, Featuring Actavis, Allergan and Topica Pharmaceuticals
May 15, 2020
Roche Becomes Founding Partner of BaseLaunch Phase II
May 14, 2020
Novartis data at ASCO and EHA showcase bold approaches to reimagine cancer and blood disorders through multiple therapeutic platforms
May 13, 2020
Worldwide Biopesticide Competitive Analysis and Leadership Study 2018 - ResearchAndMarkets.com
May 12, 2020
Extended Fiscal Year July 2019 - December 2020 Interim Report January - March 2020
May 11, 2020
Drug Delivery Devices Industry Analysis by Route of Administration, Patient Care Setting, Application and Region - Forecast to 2030, Including COVID-19's Impact
May 07, 2020
REGENXBIO Reports First Quarter 2020 Financial Results and Operational Highlights
May 06, 2020
Novartis announces FDA approval of MET inhibitor Tabrecta(TM) for metastatic non-small cell lung cancer with METex14
May 01, 2020
Sosei Heptares Notes That Enerzair® Breezhaler® (QVM149) has been Recommended for Approval in the European Union for Treating Uncontrolled Asthma
Apr 30, 2020
Anti-Asthmatics And COPD Drugs Global Market Opportunities And Strategies To 2030: COVID 19 Implications and Growth
Apr 30, 2020
Novartis US Foundation supports telehealth programs to provide access to care for New Jersey's most vulnerable communities
Apr 28, 2020
BVI Names David Murray as Chief Financial Officer
Apr 27, 2020
COVID-19 Shutdown Forces Yes on IP 34, Oregon's Psilocybin Therapy Initiative, to Change Petition Strategy in Order to Collect Remaining 15,000 Signatures
Apr 27, 2020
Mental Health Care Company COMPASS Pathways Concludes Successful Series B Investment Round
Apr 24, 2020
2020 Market Analysis for the Global Neurotrophic Keratitis Market, Featuring Key Company Profiles Including Novartis, CooperVision and Bayer AG